
JAN (NYSE:JAN – Free Report) – Investment analysts at KeyCorp issued their Q1 2026 earnings per share estimates for JAN in a research report issued to clients and investors on Tuesday, April 14th. KeyCorp analyst A. Wurschmidt forecasts that the company will post earnings per share of $0.22 for the quarter. KeyCorp has a “Overweight” rating and a $28.00 price objective on the stock. KeyCorp also issued estimates for JAN’s Q2 2026 earnings at $0.24 EPS, Q3 2026 earnings at $0.24 EPS, Q4 2026 earnings at $0.26 EPS, FY2026 earnings at $0.96 EPS, Q1 2027 earnings at $0.27 EPS, Q2 2027 earnings at $0.28 EPS, Q3 2027 earnings at $0.28 EPS, Q4 2027 earnings at $0.29 EPS and FY2027 earnings at $1.13 EPS.
A number of other analysts have also recently weighed in on JAN. Cantor Fitzgerald assumed coverage on JAN in a research note on Monday. They issued an “overweight” rating and a $27.00 price target on the stock. Scotiabank assumed coverage on JAN in a research note on Tuesday. They issued a “sector outperform” rating and a $28.00 price target on the stock. The Goldman Sachs Group assumed coverage on JAN in a research note on Tuesday. They issued a “neutral” rating and a $27.00 price target on the stock. Bank of America initiated coverage on JAN in a research note on Tuesday. They issued a “buy” rating and a $29.00 price target on the stock. Finally, Royal Bank Of Canada started coverage on JAN in a research report on Tuesday. They set an “outperform” rating and a $27.00 target price on the stock. Ten investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, JAN has an average rating of “Moderate Buy” and an average price target of $27.27.
JAN Stock Performance
JAN stock opened at $26.06 on Thursday. JAN has a 1-year low of $22.76 and a 1-year high of $26.14. The firm has a market capitalization of $6.69 billion, a price-to-earnings ratio of -62.29 and a beta of 2.16.
Insider Transactions at JAN
In related news, COO Jeffrey H. Miller purchased 7,500 shares of the company’s stock in a transaction that occurred on Monday, March 23rd. The shares were purchased at an average price of $20.00 per share, for a total transaction of $150,000.00. Following the transaction, the chief operating officer directly owned 7,500 shares of the company’s stock, valued at approximately $150,000. The trade was a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Scott M. Brinker purchased 100,000 shares of the company’s stock in a transaction that occurred on Monday, March 23rd. The stock was bought at an average price of $20.00 per share, for a total transaction of $2,000,000.00. Following the transaction, the chief executive officer directly owned 100,000 shares in the company, valued at $2,000,000. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 187,000 shares of company stock worth $3,740,000 over the last three months. 3.00% of the stock is currently owned by company insiders.
Key Headlines Impacting JAN
Here are the key news stories impacting JAN this week:
- Positive Sentiment: Bank of America started coverage with a “Buy” and $29 target — the most bullish published target among the new notes and a clear positive catalyst for investor interest. Bank of America coverage
- Positive Sentiment: KeyCorp set an “Overweight” and $28 price target, reinforcing upside expectations and likely supporting the intraday lift. KeyCorp coverage
- Positive Sentiment: Scotiabank initiated with a “Sector Outperform” and $28 target, another constructive analyst signal that can attract sector-focused funds. Scotiabank coverage
- Positive Sentiment: Wells Fargo and RBC published positive stances (Wells Fargo “Overweight”, RBC “Moderate Buy”, both with $27 targets) — more incremental analyst support helping lift sentiment. Wells Fargo / RBC coverage
- Positive Sentiment: BNP Paribas Exane added an “Outperform” with a $27 target, adding to the cluster of buy/overweight calls. BNP Paribas Exane coverage
- Neutral Sentiment: Cantor Fitzgerald initiated coverage (note: initiation itself increases visibility and can boost flows; check the initiation note for stance and target). Cantor Fitzgerald initiation
- Neutral Sentiment: JPMorgan published an “Overweight” but with a $26 target (roughly inline with the stock), a mixed signal that supports conviction but offers limited upside. JPMorgan coverage
- Negative Sentiment: Barclays also published coverage with an “Overweight” rating but a $26 target that implies slightly negative/flat near-term upside versus the recent price — a restraint on upside momentum. Barclays coverage
- Neutral Sentiment: Goldman Sachs set a “Hold” with a $27 target — less bullish than other notes and a potential cap if more investors follow a neutral stance. Goldman Sachs coverage
About JAN
Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.
Featured Stories
Receive News & Ratings for JAN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JAN and related companies with MarketBeat.com's FREE daily email newsletter.
